---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-036178"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2023-08-01T23:59:59+00:00"
generated_at: "2026-06-12T19:10:38.179253+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare restates prior financials due to sales tax error; Q2 rev $61M, cuts 4% workforce

## Summary
- Restates 2020-2022 and Q1 2023 financials over sales tax; expects G&A expense increase of $6.8M-$10.2M.
- Preliminary Q2 revenue $61M, net loss $11.4-11.8M, adj. EBITDA $17.2M; reaffirms FY revenue $249-255M and adj. EBITDA $67-71M.
- Cuts 42 jobs (~4% workforce); expects pre-tax restructuring charges of $1.8M-$2.0M in Q3 2023.
- Material weakness in internal control over financial reporting identified; Q2 2023 earnings call moved to Aug 14.

## SEC filing metadata
- accession: 0000950170-23-036178
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2023-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 2.05, 4.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/0000950170-23-036178-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/dh-20230727.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-036178
- JSON: https://secwatch.observer/filing/0000950170-23-036178.json
- Plain text: https://secwatch.observer/filing/0000950170-23-036178.txt

## Key facts
- Earnings Releases
  Definitive Healthcare Corp. reported the quarter ended June 30, 2023 results: revenue $61.0 million, net income in the range of $11.4 million to $11.8 million or $(0.08) per share, EPS $(0.08) per share. Guidance reaffirmed.
  - Period: the quarter ended June 30, 2023
  - Revenue: $61.0 million
  - Net income: in the range of $11.4 million to $11.8 million or $(0.08) per share
  - EPS: $(0.08) per share
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: Second Quarter 2023 Financial Highlights: • Revenue is expected to be $61.0 million • Net loss is expected to be in the range of $11.4 million to $11.8 million or $(0.08) per share • Adjusted Net Income is expected to be in the range of $12.3 million to $12.4 million or $0.08 per diluted share • Adjusted EBITDA is expected to be $17.2 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/0000950170-23-036178-index.htm
- Restructurings & Charges
  Definitive Healthcare Corp. announced a restructuring with charges of approximately $1.8 million to $2.0 million (42 people, or approximately 4 percent of its total workforce).
  - Type: restructuring
  - Charge: approximately $1.8 million to $2.0 million
  - Headcount: 42 people, or approximately 4 percent of its total workforce
  source text: On July 27, 2023, the Company committed to a restructuring plan (the “Plan”) intended to reduce operating costs, improve operating margins, and continue advancing the Company’s ongoing commitment to profitable growth. The Plan provides for a reduction of the Company’s current workforce by 42 people, or approximately 4 percent of its total workforce. The Company estimates that in the third quarter of 2023 it will incur pre-tax cash restructuring and related charges to its GAAP financial results of approximately $1.8 million to $2.0 million, consisting primarily of severance payments, employee benefits, and related cash expenses, as well as a non-cash charge related to the vesting of share-based awards for employees who are terminated.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/0000950170-23-036178-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.